The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Imputation methods for missing outcome data in meta-analysis of clinical trials
Open accessAbstract
Background: Missing outcome data from randomized trials lead to greater uncertainty and possible bias in estimating the effect of an experimental treatment. An intention-to-treat analysis should take account of all randomized participants even if they have missing observations. Purpose: To review and develop imputation methods for missing outcome data in meta-analysis of clinical trials with binary outcomes. Methods: We review some common strategies, such as simple imputation of positive or negative outcomes, and develop a general approach involving `informative missingness odds ratios' (IMORs). We describe several choices for weighting studies in the meta-analysis, and illustrate methods using a meta-analysis of trials of haloperidol for schizophrenia. Results: IMORs describe the relationship between the unknown risk among missing participants and the known risk among observed participants. They are allowed to differ between treatment groups and across trials. Application of IMORs and other methods to the haloperidol trials reveals the overall conclusion to be robust to different assumptions about the missing data. Limitations: The methods are based on summary data from each trial (number of observed positive outcomes, number of observed negative outcomes and number of missing outcomes) for each intervention group. This limits the options for analysis, and greater flexibility would be available with individual participant data. Conclusions: We propose that available reasons for missingness be used to determine appropriate IMORs. We also recommend a strategy for undertaking sensitivity analyses, in which the IMORs are varied over plausible ranges. Clinical Trials 2008; 5: 225—239. http://ctj.sagepub.com
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Self-citationMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Self-citationWhat is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Controlling the risk of spurious findings from meta-regression
Higgins, J. P. T., & Thompson, S. G. (2004) · Statistics in Medicine · doi:10.1002/sim.1752 · Cited by 1,267 · cited 1×
“statistically significant and has a high false-positive error rate [11].”
BackgroundSelf-citationRisperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Pattern-Mixture Models for Multivariate Incomplete Data
Little, R. J. A. (1993) · Journal of the American Statistical Association · doi:10.1080/01621459.1993.10594302 · Cited by 1,035
Joint modelling of longitudinal measurements and event time data
Henderson, R. (2000) · Biostatistics · doi:10.1093/biostatistics/1.4.465 · Cited by 913
CHOUINARD, G., JONES, B., REMINGTON, G., BLOOM, D., ADDINGTON, D., MacEWAN, G. W., LABELLE, A., BEAUCLAIR, L., & ARNOTT, W. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199302000-00004 · Cited by 876
Arvanitis, L. A., & Miller, B. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00190-x · Cited by 803
Olanzapine versus Placebo and Haloperidol
Beasley, C. M., Tollefson, G., Tran, P., Satterlee, W., Sanger, T., & Hamilton, S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00069-p · Cited by 778
A general parametric approach to the meta‐analysis of randomized clinical trials
Whitehead, A., & Whitehead, J. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101105 · Cited by 750
Wood, A. M., White, I. R., & Thompson, S. G. (2004) · Clinical Trials · doi:10.1191/1740774504cn032oa · Cited by 543
Self-citationSemiparametric Regression for Repeated Outcomes with Nonignorable Nonresponse
Rotnitzky, A., Robins, J. M., & Scharfstein, D. O. (1998) · Journal of the American Statistical Association · doi:10.1080/01621459.1998.10473795 · Cited by 445
Tashkin, D., Kanner, R., Bailey, W., Buist, S., Anderson, P., Nides, M., Gonzales, D., Dozier, G., Patel, M., & Jamerson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04724-3 · Cited by 413
Formalizing Subjective Notions about the Effect of Nonrespondents in Sample Surveys
Rubin, D. B. (1977) · Journal of the American Statistical Association · doi:10.1080/01621459.1977.10480610 · Cited by 380
Uncertainty method improved on best–worst case analysis in a binary meta-analysis
Gamble, C., & Hollis, S. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.09.013 · Cited by 238
Risperidone: clinical safety and efficacy in schizophrenia.
Borison, R. L., Pathiraja, A., Diamond, B. I., & Meibach, R. C. (1992) · PubMed · Cited by 210
Haloperidol versus placebo for schizophrenia
Adams, C. E., Bergman, H., Irving, C. B., & Lawrie, S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003082.pub3 · Cited by 159
Aversive smoking for smoking cessation
Hájek, P., & Stead, L. F. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000546.pub2 · Cited by 125
Allowing for uncertainty due to missing data in meta‐analysis—Part 1: Two‐stage methods
White, I. R., Higgins, J. P. T., & Wood, A. (2007) · Statistics in Medicine · doi:10.1002/sim.3008 · Cited by 115
Self-citationA New Approach to the Analysis of Clinical Drug Trials with Withdrawals
Gould, A. L. (1980) · Biometrics · doi:10.2307/2556126 · Cited by 113
Haloperidol in schizophrenic children: early findings from a study in progress.
SPENCER, E. K., Kafantaris, V., Padron-Gayol, M., Rosenberg, C. R., & Campbell, M. (1992) · PubMed · Cited by 101
Nordheim, E. V. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10477094 · Cited by 99
Scharfstein, D. O., Daniels, M. J., & Robins, J. M. (2003) · Biostatistics · doi:10.1093/biostatistics/4.4.495 · Cited by 83
Sensitivity analysis for incomplete categorical data
Kenward, M. G., Goetghebeur, E. J. T., & Molenberghs, G. (2001) · Statistical Modelling · doi:10.1177/1471082x0100100104 · Cited by 77
A graphical sensitivity analysis for clinical trials with non‐ignorable missing binary outcome
Hollis, S. (2002) · Statistics in Medicine · doi:10.1002/sim.1276 · Cited by 50
HALOPERIDOL, CLOPENTHIXOL, AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA
Serafetinides, E. A., COLLINS, S., & Clark, M. L. (1972) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197201000-00005 · Cited by 41
HALOPERIDOL, CLOPENTHIXOL, AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA
Serafetinides, E. A., WILLIS, D., & Clark, M. L. (1972) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197211000-00010 · Cited by 40
Prophylactic effect of neuroleptics in symptom-free schizophrenics
Nishikawa, T., Tsuda, A., Tanaka, M., Koga, I., & Uchida, Y. (1982) · Psychopharmacology · doi:10.1007/bf00432759 · Cited by 32
Magder, L. S. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00021-7 · Cited by 28
Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
Fb, S., Rf, M., & Helwig, H. (1976) · PubMed · Cited by 26
Miller, M. E., Morgan, T. M., Espeland, M. A., & Emerson, S. S. (2001) · Statistics in Medicine · doi:10.1002/sim.904 · Cited by 20
A controlled study of haloperidol in chronic schizophrenia.
Gm, S., Angus, J. W. S., & Jg, E. (1967) · PubMed · Cited by 19
Cited by
How to perform a meta-analysis with R: a practical tutorial
Balduzzi, S., Rücker, G., & Schwarzer, G. (2019) · Evidence Based Mental Health · doi:10.1136/ebmental-2019-300117 · Cited by 5,827
Systematic reviews: CRD's guidance for undertaking reviews in health care
Tacconelli, E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70065-7 · Cited by 3,245
Analysing data and undertaking meta‐analyses
Deeks, J. J., Higgins, J. P., Altman, D. G., & on behalf of the Cochrane Statistical Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch10 · Cited by 2,672
Self-citationAnalysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Self-citationAssessing risk of bias in a randomized trial
Higgins, J. P., Savović, J., Page, M. J., Elbers, R. G., & Sterne, J. A. (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch8 · Cited by 1,765
Self-citation
Metadata
- Authors
- Higgins, J. P., White, I. R., & Wood, A. M.
- Venue
- Clinical Trials
- Publisher
- SAGE Publications
- Published
- 2008-06
- Volume
- 5
- Issue
- 3
- Pages
- 225-239
- ISSN
- 1740-7745 (ISSN-L)
- 1740-7753
- OpenAlex
- W2097744101
- Cited by
- 352
- References
- 38
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.